Neonatal jaundice: physiologic variation or pathologic process

Area of Science:

• Neonatology
• Pediatrics
• Biochemistry

Background:

• Neonatal hyperbilirubinemia and jaundice are common conditions affecting roughly 60% of newborns in the US annually.
• Jaundice is clinically apparent when serum bilirubin levels reach 5-7 mg/dL due to deposition in skin and mucous membranes.
• Elevated bilirubin levels pose a risk for bilirubin-induced neurological damage in infants.

Purpose of the Study:

• To summarize the prevalence and potential risks associated with neonatal hyperbilirubinemia.
• To define the clinical significance of bilirubin levels in newborns.
• To underscore the importance of understanding bilirubin's neurotoxicity.

Main Methods:

• Literature review on neonatal jaundice.
• Analysis of bilirubin metabolism and deposition.
• Review of clinical guidelines for hyperbilirubinemia management.

Main Results:

• Jaundice affects approximately 60% of US newborns annually.
• Clinical jaundice is visible at serum bilirubin levels of 5-7 mg/dL.
• Bilirubin deposition in the brain can cause neurological impairment.

Conclusions:

• Neonatal hyperbilirubinemia is a prevalent condition requiring attention.
• Monitoring serum bilirubin levels is crucial for preventing neurological sequelae.
• Further research is needed to define the critical bilirubin threshold for neurotoxicity.